HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wernicke's encephalopathy associated with hemodialysis: report of two cases and review of the literature.

Abstract
Two rare cases of Wernicke's encephalopathy (WE) in non-alcoholic patients on hemodialysis (HD) are reported. They presented with the clinical triad of WE (ophthalmoplegia, ataxia and disturbance of consciousness) and intravenous administration of thiamine led to complete elimination of these manifestations. Reduced plasma thiamine levels prior to the administration confirmed the diagnosis of WE. Interestingly, a reduction in plasma thiamine levels by about half was seen in one of the patients on HD, suggesting that thiamine, a water-soluble vitamin, can be depleted with HD. In the literature, nine HD-dependent patients have been reported to develop WE, seven of whom were diagnosed postmortem. Their premortem diagnoses included uremic encephalopathy, dysequilibrium syndrome and dialysis dementia, which can often complicate HD and present symptoms similar to those of WE. We therefore emphasize that WE, even though a rare complication, should be suspected in all patients on HD who present with at least one of the clinical triad of WE.
AuthorsM Ihara, T Ito, C Yanagihara, Y Nishimura
JournalClinical neurology and neurosurgery (Clin Neurol Neurosurg) Vol. 101 Issue 2 Pg. 118-21 (Jun 1999) ISSN: 0303-8467 [Print] Netherlands
PMID10467908 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Thiamine
Topics
  • Aged
  • Confidence Intervals
  • Humans
  • Male
  • Renal Dialysis (adverse effects)
  • Thiamine (blood, therapeutic use)
  • Treatment Outcome
  • Wernicke Encephalopathy (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: